Alston & Bird allege their client has suffered more than $1 billion in lost sales from being unable to manufacture a ...

Amgen has shared positive results from a late-stage study of its immunotherapy Imdelltra (tarlatamab-dlle) in small cell lung cancer (SCLC). The global DeLLphi-304 trial has been comparing the drug ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target ...

TD Cowen analyst Yaron Werber maintained a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today and set a price target of $59.00.

Initiative had its fourth consecutive year of double-digit revenue growth, as the agency posted a 12% increase in revenue and a 10% rise in organic growth in 2024.

During a recent panel discussion sponsored by Purdue University, industry leaders explain how the technology is revolutionizing drug development and production ...

The escalating US-China trade war is affecting the pharmaceutical sector, as tariff increases on US-made drugs strain drugmakers' costs. Counterfeit versions of Novo Nordisk’s Ozempic surfaced in the ...

While 2025 began on a positive note for the pharmaceutical industry, things have taken a sharp turn amid escalating fears of a global trade war. While Trump had initially exempted pharmaceuticals from ...

Major indices headed south on Tuesday as traders digested a fresh batch of Q1 earnings from more of the nation's biggest ...

Zuckerman Investment Group injected $521,000 into Amgen by scooping up 1,803 shares during the fourth quarter. A crowd of other investors also hopped aboard the Amgen train, with stakes both large and ...

Heritage Trust Co just grabbed 9,510 shares of Lowe’s Companies, adding some DIY love to its portfolio this quarter. This isn’t a solo home improvement project—major players like Norges Bank and ...